Secondary prophylaxis for group A streptococcal infection (acute rheumatism, Sydenham's chorea), prophylaxis for sickle cell anaemia and (functional) asplenia
The prophylaxis of sickle cell anaemia can be discontinued after the age of 12 years unless the case history includes pneumococcal sepsis or meningitis. In that event, the prophylaxis should be lifelong.
In actual or functional asplenia, treatment should continue up to the age of 6 (and up to 2 years after splenectomy)
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Food possibly slows the resorption of phenoxymethylpenicillin and concentrations in the blood are lower as a result; should preferably be taken 1 hour before or 2 hours after a meal. If this causes compliance issues, phenoxymethylpenicillin can be taken with food.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Chaudhary S et al. , Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. , J Pediatr. , 1985 , Mar;106(3), 481-6
Fujita K et al. , Comparative pharmacological evaluation of oral benzathine penicillin G and phenoxymethyl penicillin potassium in children., Pediatr Pharmacol (New York). , 1983, 3(1):, 37-41.
Gerber MA et al. , Potential mechanisms for failure to eradicate group A streptococci from the pharynx. , Pediatrics. , 1999 , Oct;104(4 Pt 1):, 911-7
Heijboer H et al. , Preventie bij en begeleiding van kinderen met sikkelcelziekte en hun ouders. Deel I. Tweede herziene leidraad. , www.nvk.nl, Mei 2014.
LCI. , Richtlijn voor preventie van infecties bij mensen met (functionele) hypo- en asplenie., 2018
Gaston MH et al., Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial., N Engl J Med, 1986 , Jun 19;314(25), 1593-9
Hirst C et al. , Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease., Cochrane Database Syst Rev., 2014 , Nov 6;(11), CD003427
Choeyprasert W. , Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis., Int J Hematol., 2017 , Feb;105(2), 213-220
SKION. , Werkboek Supportive care. H2. , www.skion.nl, December 2017
1A Pharma, SmPC Pen 0,4 Mega TS 400.000 I.E./5 ml Granulat zur Herstellung einer Lösung zum Einnehmen (57982.00.00, 05/2018
Sanofi, SmPC Isocillin Saft 300.000 I.E. /5 ml Pulver zur Herstellung einer Lösung zum Einnehmen (14014.00.00), 02/2018